ICON Late Phase and Outcomes Research deliver strategic expertise, high-impact evidence that explores and demonstrates value of healthcare products and meets the demands of the global and national markets for patient reported outcome services.
We deliver strategic expertise, high-impact evidence that explores and demonstrates value of healthcare products in the major European, Asian and North American markets.
Our ability to provide clients with effectively integrated services is one of our strengths. We can also integrate these services with market access, reimbursement and marketing strategies along with ICON’s other patient reported outcomes, epidemiology, market research and medical writing services.
We are able to explore and demonstrate value in healthcare products at key product development stages:
Patient Reported Outcomes Services (PRO, ePRO)
ICON Late Phase and Outcomes Research patient reported outcome services are geared to meet the demands of global and national markets and include:
In project-work, the PRO team is able to closely integrate with clients and our colleagues in health economics, epidemiology, biostatistics and translation teams to provide strategic advice and services that support the entire product development life cycle covering:
Strategic Market Access
ICON's in-depth global knowledge of reimbursement processes and healthcare systems, ability to generate supporting scientific evidence, and strength rength in scientific communication to offer a full range of leading scientific services that devise and support market access strategies. Icon provides a number of services to support decision-making in market access. These include: